Capillary Electrophoresis Method for the Chiral Purity Determination of Pregabalin Derivatized with Dansyl Chloride
- 124 Downloads
A capillary electrophoresis method for the determination of the chiral purity of pregabalin upon derivatization with dansyl chloride was developed using design of experiment methodologies. A D-optimal design was used for the identification of the critical process parameters, while a central composite face centered design and Monte Carlo simulations were employed for defining the design space of the method. Final working conditions consisted of a background electrolyte composed of a 100 mM sodium phosphate buffer, pH 2.5, containing 40 mg mL−1 heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin, a separation voltage of 15 kV and a capillary temperature of 25 °C. The analyses were carried out in a 40/50.2 cm fused-silica capillary with an inner diameter of 50 µm. Upon testing the robustness using a Plackett–Burman design, the method was validated according to the International Council on Harmonization guideline Q2(R1). The method allowed the detection of the (R)-enantiomer at the 0.015% level with a limit of quantitation at the 0.05% level with regard to a sample containing 1.59 mg mL−1 pregabalin. The method was subsequently applied to the determination of the stereochemical purity of the drug in commercial capsules.
KeywordsPregabalin Enantiomeric purity Stereoisomer analysis Capillary electrophoresis Quality by design
The gift of pregabalin and the racemic drug by Optimus Drugs PVT Ltd. (Hyderabad, India) is gratefully acknowledged.
Compliance with Ethical Standards
Conflict of interest
The authors have declared no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 1.European Medicines Agency (2017) Lyrica—product information. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000546/WC500046602.pdf. Accessed 10 Nov 2017
- 4.Monograph Pregabalin (2017) European Pharmacopoeia, 9th edn. European Directorate for the Quality of Medicines and HealthCare, StrasbourgGoogle Scholar
- 5.Monograph Pregabalin (2018) The United States Pharmacopeia, 41st edn. The United States Pharmacopeial Convention, RockvilleGoogle Scholar
- 7.Liu H, Pan Y, Qin F, Liu C, Li S, Du D, Chen R (2012) Method for separating and determining pregabalin chiral isomer by electrophoretically mediated microanalysis. Chinese Patent CN 102375037Google Scholar
- 8.Rajan N, Anver basha K (2014) A novel reverse phase high performance liquid chromatography method for enantiomeric resolution of pregabalin with immobilized zwitterionic stationary phases. J Pharm Res 8:1563–1569Google Scholar
- 9.Zhang T, Holder E, Franco P, Lindner W (2014) Method development and optimization on cinchona and chiral sulfonic acid-based zwitterionic stationary phases for enantiomer separations of free amino acids by high-performance liquid chromatography. J Chromatogr A 1363:191–199. https://doi.org/10.1016/j.chroma.2014.06.012 CrossRefGoogle Scholar
- 10.Chennuru LN, Choppari T, Nandula RP, Zhang T, Franco P (2016) Direct separation of pregabalin enantiomers using a zwitterionic chiral selector by high performance liquid chromatography coupled to mass spectrometry and ultraviolet detection. Molecules 21:1578. https://doi.org/10.3390/molecules21111578 CrossRefGoogle Scholar
- 16.Béni S, Sohajda Neumajer G, Iványi R, Szente L, Noszál B (2010) Separation and characterization of modified pregabalins in terms of cyclodextrin complexation, using capillary electrophoresis and nuclear magnetic resonance. J Pharm Biomed Anal 51:842–852. https://doi.org/10.1016/j.jpba.2009.10.010 CrossRefGoogle Scholar
- 21.International Council on Harmonization guideline Q2 (R1). Validation of analytical procedures: text and methodology. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf. Last accessed 10 Oct 2017